Tiny implant could ease glaucoma pressure

NCT ID NCT06176170

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called the VividWhite Glaucoma Implant, which is surgically placed in the eye to help lower pressure in people with glaucoma. Sixty-five participants will be followed for 12 months to see if the implant safely reduces eye pressure and lessens the need for medication. The goal is to offer a long-term treatment option for this common eye condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
VividWhite Glaucoma Implant (VW-51) – a small device surgically placed in the eye to help drain fluid and lower pressure.
What this could lead to
If successful, this implant could provide a new way to control eye pressure and reduce the need for daily eye drops in people with glaucoma.
What could go wrong
This is a small, early-stage study with no comparison group, so results may not apply to everyone. The implant could cause side effects like infection or require additional surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC ANGLE CLOSURE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cataract & Eye Surgery Centre

    Doncaster East, Victoria, 3109, Australia

  • Cerulea Clinical Trials, Centre for Eye Research Australia

    East Melbourne, Victoria, 3002, Australia

  • Eye Surgery Associates

    Vermont South, Victoria, 3133, Australia

  • Flinders Medical Centre

    Bedford Park, South Australia, 5042, Australia

  • Melbourne Eye Specialists

    Fitzroy, Victoria, 3065, Australia

  • Sydney Eye Hospital

    Sydney, New South Wales, 2000, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.